Suchbegriffe: GUILLAIN-BARRE SYNDROME, . Treffer: 14
Jarius, S; Pache, F; Körtvelyessy, P; Jelčić, I; Stettner, M; Franciotta, D; Keller, E; Neumann, B; Ringelstein, M; Senel, M; Regeniter, A; Kalantzis, R; Willms, JF; Berthele, A; Busch, M; Capobianco, M; Eisele, A; Reichen, I; Dersch, R; Rauer, S; Sandner, K; Ayzenberg, I; Gross, CC; Hegen, H; Khalil, M; Kleiter, I; Lenhard, T; Haas, J; Aktas, O; Angstwurm, K; Kleinschnitz, C; Lewerenz, J; Tumani, H; Paul, F; Stangel, M; Ruprecht, K; Wildemann, B, , ; in, cooperation, with, the, German, Society, for, Cerebrospinal, Fluid, Diagnostics, and, Clinical, Neurochemistry
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
J Neuroinflammation. 2022; 19(1): 19
Doi: 10.1186/s12974-021-02339-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Amereller, F; Lottspeich, C; Buchholz, G; Dichtl, K
A horse and a zebra: an atypical clinical picture including Guillain-Barré syndrome, recurrent fever and mesenteric lymphadenopathy caused by two concomitant infections.
Infection. 2020; 48(3): 471-475.
Doi: 10.1007/s15010-020-01397-5
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nardone, R; Christova, M; Bratti, A; Lochner, P; Covi, M; Trinka, E; Tezzon, F; Golaszewski, S
Corticospinal tract dysfunction in a patient with acute motor axonal neuropathy (AMAN).
Clin Neurol Neurosurg. 2011; 113(9): 779-781.
Doi: 10.1016/j.clineuro.2011.07.022
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Quasthoff, S; Pojer, C; Mori, A; Hofer, D; Liebmann, P; Kieseier, BC; Schreibmayer, W
No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve.
Neurosci Lett. 2003; 352(2):93-96
Doi: 10.1016/S0304-3940(03)01014-0
Web of Science
PubMed
FullText
FullText_MUG
Kieseier, BC; Tani, M; Mahad, D; Oka, N; Ho, T; Woodroofe, N; Griffin, JW; Toyka, KV; Ransohoff, RM; Hartung, HP
Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.
Brain. 2002; 125(Pt 4):823-834
Doi: 10.1093/brain/awf070
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Andorfer, B; Kieseier, BC; Mathey, E; Armati, P; Pollard, J; Oka, N; Hartung, HP
Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system.
J Neuroimmunol. 2001; 116(2):226-232
Doi: 10.1016%2FS0165-5728%2801%2900306-X
Web of Science
PubMed
FullText
FullText_MUG
Skundric, DS; Lisak, RP; Rouhi, M; Kieseier, BC; Jung, S; Hartung, HP
Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions.
J Neuroimmunol. 2001; 116(1):74-82
Doi: 10.1016%2FS0165-5728%2801%2900281-8
Web of Science
PubMed
FullText
FullText_MUG
Hartung, HP; Kieseier, BC
The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.
J Neuroimmunol. 2000; 107(2):140-147
Doi: 10.1016%2FS0165-5728%2800%2900225-3
Web of Science
PubMed
FullText
FullText_MUG
Kieseier, BC; Krivacic, K; Jung, S; Pischel, H; Toyka, KV; Ransohoff, RM; Hartung, HP
Sequential expression of chemokines in experimental autoimmune neuritis.
J Neuroimmunol. 2000; 110(1-2):121-129
Doi: 10.1016%2FS0165-5728%2800%2900323-4
Web of Science
PubMed
FullText
FullText_MUG
Gold, R; Oelschläger, M; Pepinsky, RB; Sommer, C; Hartung, HP; Toyka, KV
Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis.
Acta Neuropathol (Berl). 1999; 98(6):583-589
Doi: 10.1007%2Fs004010051122
Web of Science
PubMed
FullText
FullText_MUG
Kieseier, BC; Seifert, T; Hartung, HP
Matrix metalloproteinases. Potential targets for new treatments in inflammatory demyelinating diseases of the nervous system
NERVENARZT 1999 70: 509-516.
Doi: 10.1007/s001150050473
Web of Science
PubMed
FullText
FullText_MUG
Previtali, SC; Archelos, JJ; Hartung, HP
Expression of integrins in experimental autoimmune neuritis and Guillain-Barré syndrome.
Ann Neurol. 1998; 44(4):611-621
Doi: 10.1002/ana.410440406
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Hartung, HP; Gold, R; Zielasek, J; Archelos, JJ; Toyka, KV
Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)
NERVENARZT. 1994; 65(12): 807-818.
Web of Science
PubMed
HARTUNG, HP; JUNG, SF; STOLL, G; ZIELASEK, J; SCHMIDT, B; ARCHELOS, JJ; TOYKA, KV
Inflammatory mediators in demyelinating disorders of the CNS and PNS.
J Neuroimmunol. 1992; 40(2-3):197-210
Doi: 10.1016/0165-5728(92)90134-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar